|
|
||||||||
ORIGINAL RESEARCH |
From the School of Health Sciences and the Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
Address reprint requests to: Toshinori Fujino, MD School of Health Sciences Kagoshima University 8-35-1 Sakuragaoka Kagoshima, 890-8506 Japan E-mail: toshinet{at}health.nop.kagoshima-u-ac-jp
Objective: The mechanism by which the placenta serves as the barrier against mother-to-fetus transmission of microorganisms remains to be elucidated. Programmed cell death, apoptosis, is considered a cellular defense mechanism against infection. The hypothesis of this study is that apoptosis of human T-lymphotropic virus type I (HTLV-I)infected placental villous cells is involved in the defense mechanism against mother-to-fetus transmission of HTLV-I.
Methods: Apoptosis was compared in term placentas from eight HTLV-Iseropositive pregnant women and eight HTLV-Iseronegative pregnant women by the terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end-labeling method. In addition, an in vitro cocultivation with an HTLV-Iinfected lymphocyte cell line (MT-2 cells) was performed to examine whether placental villous cells were infected with HTLV-I and apoptosis was induced.
Results: The incidence of apoptosis-positive cells (nuclei) in placentas from the HTLV-Iseropositive pregnant women was higher than in the HTLV-Iseronegative pregnant women (P < .02). Cocultivation with MT-2 cells showed that trophoblast cells were able to be infected with HTLV-I and that apoptosis was induced in the placental villous cells.
Conclusion: HTLV-I infection induces apoptosis in the placenta. We speculate that apoptosis may be involved in the defense mechanism of the placenta against mother-to-fetus transmission of HTLV-I.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |